Perspectives and conclusions Tirzepatide has demonstrated marked and dose-dependent reductions in glycemic parameters in patients with T2D that, according to the present study data, surpass the effects of the GLP-1RA dulaglutide and semaglutide (54, 66, 67, 71)
Thyroid function testing is recommended when symptoms suggest thyroid dysfunction
There is no recognised clinical condition called Ozempic personality
SE: Resources, Conceptualization, Funding acquisition, Writing review and editing
Patients carrying certain variants in genes related to glucose-dependent renal reabsorption may experience glucosuria (glucose in urine) at higher rates when on semaglutide, providing additional substrate for bacterial growth
P=0.012), but not with changes in serum ammonia levels (R2=0.005